• Dextrose (D-glucose): Advancing Hypoxia and Immunometabolism

  2026-05-31

  Explore how Dextrose (D-glucose) enables mechanistic insights into tumor hypoxia, metabolic reprogramming, and immunometabolic adaptation. This thought-leadership article bridges the gap between experimental validation and translational strategy, providing protocol parameters, workflow guidance, and a strategic outlook for researchers seeking to unlock the therapeutic potential of glucose metabolism in the tumor microenvironment.

• E-64: Strategic Cysteine Protease Inhibition for Translation

  2026-05-30

  Explore how E-64, a potent L-trans-epoxysuccinyl peptide, is transforming mechanistic research on cysteine proteases. This thought-leadership article navigates the latest findings on cathepsin inhibition, experimental best practices, and translational research strategy—framing E-64’s role in advancing cancer, cell death, and disease modeling applications. With evidence from preclinical studies and expert guidance, we chart a visionary path for integrating E-64 into next-generation workflows.

• AG-490 (Tyrphostin B42): Advanced Modulation of JAK2/STAT6 i

  2026-05-29

  Explore how AG-490 (Tyrphostin B42) enables precise inhibition of the JAK2/STAT6 pathway, advancing cancer immunology and macrophage polarization research. This in-depth article uniquely analyzes assay design, reference breakthroughs, and practical workflow considerations for modern tumor microenvironment studies.

• Localized Muscle BDNF Release Directs Early NMJ Synapse Asse

  2026-05-29

  This study demonstrates that spatially regulated, muscle-generated BDNF release is essential for the initial formation of postsynaptic acetylcholine receptor clusters at vertebrate neuromuscular junctions. By dissecting the trafficking and proteolytic conversion of BDNF—including the role of furin and MMPs—the research provides a mechanistic framework for understanding synaptic assembly and offers actionable points for experimental intervention.

• FLOT1–FOSL2–EphA2 Axis Drives Microglial Polarization in AD

  2026-05-28

  This study uncovers how the interaction between FLOT1 and FOSL2 upregulates EphA2 transcription, activating the p38/MAPK pathway to promote pro-inflammatory microglial polarization in Alzheimer's disease. By disrupting this axis in APP/PS1 mice, researchers observed reduced neuroinflammation and improved cognitive function, highlighting a promising target for therapeutic intervention and the refinement of neurotoxicity models.

• Lopinavir (ABT-378): Optimizing HIV Protease Inhibition Assa

  2026-05-28

  Lopinavir (ABT-378) stands apart for its nanomolar-range potency and exceptional stability in HIV protease inhibition workflows, especially in the presence of serum proteins. This article delivers actionable protocols, troubleshooting strategies, and comparative insights to harness Lopinavir’s capabilities for advanced antiviral and resistance research.

• Naftifine HCl: Allylamine Antifungal Agent for Research Use

  2026-05-27

  Naftifine HCl is a high-purity allylamine antifungal agent that selectively inhibits squalene 2,3-epoxidase, disrupting fungal cell membrane biosynthesis. It is primarily used for topical dermatophytic infections and is supplied for research purposes only. Its robust solubility profile and established purity make it a benchmark for antifungal mechanism studies.

• Angiotensin Peptide Fragments Enhance SARS-CoV-2 Spike–AXL B

  2026-05-27

  The reference study reveals that naturally occurring angiotensin peptides—including N-terminally truncated fragments—markedly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, a process distinct from canonical ACE2 engagement. These findings highlight a molecular interface between the renin–angiotensin system and viral entry, with implications for cardiovascular and infectious disease research.

• Phosbind Acrylamide: Transforming Phosphorylation Analysis W

  2026-05-26

  Phosbind Acrylamide enables precise, antibody-free detection of protein phosphorylation states by leveraging phosphate-binding chemistry within SDS-PAGE gels. This reagent streamlines workflows in signaling research, providing superior mobility shift resolution and directly supporting advanced post-translational modification studies.

• Docetaxel in Cancer Research: Optimizing Experimental Workfl

  2026-05-26

  Docetaxel’s unique ability to stabilize microtubules makes it indispensable for cancer chemotherapy research and dissecting apoptosis in challenging tumor models. This guide translates the latest mechanistic insights and published innovations into actionable workflows, troubleshooting strategies, and comparative advantages for advanced oncology labs.

• D-Luciferin in Translational Oncology: Mechanistic Rigor & A

  2026-05-25

  Discover how D-Luciferin, a premier firefly luciferase substrate, is transforming intracellular ATP quantification and metastatic cancer research through mechanistic insight and advanced assay protocols. This article uniquely connects new findings in colorectal cancer biology with practical bioluminescence imaging strategies.

• Ruthenium Red in Mechanotransduction: Strategic Guidance for

  2026-05-25

  Explore the mechanistic foundation and translational applications of Ruthenium Red as a potent Ca2+ transport inhibitor in cytoskeleton-dependent autophagy and mechanotransduction. This article synthesizes breakthrough findings, actionable protocol guidance, and strategic insight for researchers aiming to advance calcium signaling research and translational workflows.

• Methoxy-X04: Fluorescent Amyloid Beta Probe in AD Research

  2026-05-24

  Methoxy-X04 distinguishes itself as a brain-permeable fluorescent amyloid beta probe, delivering rapid, high-contrast imaging for both oligomer and fibril detection in Alzheimer's disease models. Its robust affinity, reliable blood-brain barrier penetration, and compatibility with live animal imaging workflows make it a benchmark tool for quantifying amyloid pathology and accelerating translational neuroscience.

• Plk1 Regulation of p31comet and Mitotic Checkpoint Disassemb

  2026-05-23

  This study elucidates how Polo-like kinase 1 (Plk1) directly regulates the checkpoint protein p31comet via phosphorylation, controlling the disassembly of mitotic checkpoint complexes and ensuring accurate chromosome segregation. These findings clarify a critical mechanism coordinating mitotic progression and have methodological implications for cell cycle and cancer research.

• NU7441 (KU-57788) DNA-PK Inhibitor: Protocols & Innovations

  2026-05-22

  NU7441 (KU-57788) is redefining DNA repair and oncology research by enabling precise modulation of DNA damage response pathways. This article explores actionable workflows, emerging cross-domain applications, and troubleshooting tactics, with insights drawn from leading publications and the latest HIV latency research.

446 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page